Nautilus Biotechnology, Inc. (NAUT) Financials
NAUT Assets vs Liabilities
Date | Assets | Liabilities |
---|---|---|
2023-12-31 | 305.6 million | 40.2 million |
2023-09-30 | 318.3 million | 41.1 million |
2023-06-30 | 330.8 million | 41.1 million |
2023-03-31 | 345.9 million | 42.2 million |
NAUT Free Cash Flow and Stock based compensation
Graph available only for supporters. Become a supporter to see it.
Date | Free Cash Flow | Stock based compensation |
---|---|---|
2023-12-31 | -14.3 million | 3.1 million |
2023-09-30 | -12.6 million | 3.1 million |
2023-06-30 | -14.0 million | 3.1 million |
2023-03-31 | -13.2 million | 2.9 million |
NAUT Net Income
Graph available only for supporters. Become a supporter to see it.
Date | Net Income |
---|---|
2023-12-31 | -17.0 million |
2023-09-30 | -15.9 million |
2023-06-30 | -15.8 million |
2023-03-31 | -15.0 million |
NAUT Cash and Debt
Graph available only for supporters. Become a supporter to see it.
Date | Cash | Debt | Capital Lease |
---|---|---|---|
2023-12-31 | 173.4 million | - | 34.6 million |
2023-09-30 | 183.3 million | - | 35.6 million |
2023-06-30 | 163.3 million | - | 36.5 million |
2023-03-31 | 167.3 million | - | 37.3 million |
NAUT Shares Outstanding
NAUT Expenses
Graph available only for supporters. Become a supporter to see it.
Date | Capex | R&D | G&A | S&M |
---|---|---|---|---|
2023-12-31 | 413000 | 12.5 million | 7.5 million | - |
2023-09-30 | 874000 | 12.0 million | 7.1 million | - |
2023-06-30 | 463000 | 11.9 million | 7.1 million | - |
2023-03-31 | 692000 | 10.9 million | 7.2 million | - |
NAUT Cost of Revenue
Graph available only for supporters. Become a supporter to see it.
Date | Revenue | Cost of Revenue |
---|---|---|
2023-12-31 | - | 1.6 million |
2023-09-30 | - | 1.5 million |
2023-06-30 | - | 1.4 million |
2023-03-31 | - | 1.2 million |
NAUT
Price: $2.69
52 week price:
Earnings Per Share: -0.51 USD
P/E Ratio: -5.87
Exchange: NMS
Sector: Healthcare
Industry: Biotechnology
Volume: 189600
Market Capitalization: 346.5 million